Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.

Literature DB >> 25808917

Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.

Mario Tiribelli¹, Gianni Binotto², Elisabetta Calistri³, Elena Maino⁴, Luigi Scaffidi⁵, Marta Medeot¹, Mitja Nabergoj², Achille Ambrosetti⁵, Gianpietro Semenzato², Renato Fanin¹, Massimiliano Bonifacio⁵.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 25808917 DOI： 10.1002/ajh.24022

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.

Authors: Ya-Zhen Qin; Qian Jiang; Hao Jiang; Yue-Yun Lai; Hong-Hu Zhu; Yan-Rong Liu; Bin Jiang; Xiao-Jun Huang
Journal: Medicine (Baltimore) Date: 2016-01 Impact factor: 1.817

1 in total